The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Are the cardiac effects of anabolic steroid abuse in strength athletes reversible?
Open accessAbstract
Objective: To investigate the reversibility of adverse cardiovascular effects after chronic abuse of anabolic androgenic steroids (AAS) in athletes. Methods: Doppler echocardiography and cycle ergometry including measurements of blood pressure at rest and during exercise were undertaken in 32 bodybuilders or powerlifters, including 15 athletes who had not been taking AAS for at least 12 months (ex-users) and 17 currently abusing AAS (users), as well as in 15 anabolic-free weightlifters. Results: Systolic blood pressure was higher in users (mean (SD) 140 (10) mm Hg) than in ex-users (130 (5) mm Hg) (p < 0.05) or weightlifters (125 (10) mm Hg; p < 0.001). Left ventricular muscle mass related to fat-free body mass and the ratio of mean left ventricular wall thickness to internal diameter were not significantly higher in users (3.32 (0.48) g/kg and 42.1 (4.4)%) than in ex-users (3.16 (0.53) g/kg and 40.3 (3.8)%), but were lower in weightlifters (2.43 (0.26) g/kg and 36.5 (4.0)%; p < 0.001). Left ventricular wall thickness related to fat-free body mass was also lower in weightlifters, but did not differ between users and ex-users. Left ventricular wall thickness was correlated with a point score estimating AAS abuse in users (r = 0.49, p < 0.05). In all groups, systolic left ventricular function was within the normal range. The maximum late transmitral Doppler flow velocity (Amax) was higher in users (61 (12) cm/s) and ex-users (60 (12) cm/s) than in weightlifters (50 (9) cm/s; p < 0.05 and p = 0.054). Conclusions: Several years after discontinuation of anabolic steroid abuse, strength athletes still show a slight concentric left ventricular hypertrophy in comparison with AAS-free strength athletes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings
Devereux, R. B., Alonso, D. R., Lutas, E. M., Gottlieb, G. J., Campo, E., Sachs, I., & Reichek, N. (1986) · The American Journal of Cardiology · doi:10.1016/0002-9149(86)90771-x · Cited by 6,229
Levy, D., Garrison, R. J., Savage, D. D., Kannel, W. B., & Castelli, W. P. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005313222203 · Cited by 5,699
The Upper Limit of Physiologic Cardiac Hypertrophy in Highly Trained Elite Athletes
Pelliccia, A., Maron, B. J., Spataro, A., Proschan, M. A., & Spirito, P. (1991) · New England Journal of Medicine · doi:10.1056/nejm199101313240504 · Cited by 1,019
Androgen Receptors Mediate Hypertrophy in Cardiac Myocytes
Marsh, J. D., Lehmann, M. H., Ritchie, R. H., Gwathmey, J. K., Green, G. E., & Schiebinger, R. J. (1998) · Circulation · doi:10.1161/01.cir.98.3.256 · Cited by 432
The cardiac toxicity of anabolic steroids
Sullivan, M. L., Martinez, C. M., Gennis, P., & Gallagher, E. J. (1998) · Progress in Cardiovascular Diseases · doi:10.1016/s0033-0620(98)80019-4 · Cited by 342
(1990) · New England Journal of Medicine · doi:10.1056/nejm199012133232413 · Cited by 323
Anabolic-Androgenic Steroids: Current Issues
Yesalis, C. E., & Bahrke, M. S. (1995) · Sports Medicine · doi:10.2165/00007256-199519050-00003 · Cited by 281
Increased Premature Mortality of Competitive Powerlifters Suspected to Have Used Anabolic Agents
Pärssinen, M., Kujala, U., Vartiainen, E., Sarna, S., & Seppälä, T. (2000) · International Journal of Sports Medicine · doi:10.1055/s-2000-304 · Cited by 199
Serious cardiovascular side effects of large doses of anabolic steroids in weight lifters
Nieminen, M. S., Ramo, M. P., Viitasalo, M., Heikkila, P., Karjalainen, J., Mantysaari, M., & Heikkila, J. (1996) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a014724 · Cited by 178
Cause and Manner of Death Among Users of Anabolic Androgenic Steroids
Thiblin, I., Lindquist, O., & Rajs, J. (2000) · Journal of Forensic Sciences · doi:10.1520/jfs14635j · Cited by 156
Cited by
Sagoe, D., Molde, H., Andreassen, C. S., Torsheim, T., & Pallesen, S. (2014) · Annals of Epidemiology · doi:10.1016/j.annepidem.2014.01.009 · Cited by 686
Role of β-Adrenoceptor Signaling in Skeletal Muscle: Implications for Muscle Wasting and Disease
Lynch, G. S., & Ryall, J. G. (2008) · Physiological Reviews · doi:10.1152/physrev.00028.2007 · Cited by 410
Kanayama, G., Hudson, J. I., & Pope, H. G. (2008) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2008.05.004 · Cited by 404
Pelliccia, A., Caselli, S., Sharma, S., Basso, C., Bax, J. J., Corrado, D., D’Andrea, A., D’Ascenzi, F., Di Paolo, F. M., Edvardsen, T., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehx532 · Cited by 368
Adverse effects of anabolic steroids in athletes
Maravelias, C., Dona, A., Stefanidou, M., & Spiliopoulou, C. (2005) · Toxicology Letters · doi:10.1016/j.toxlet.2005.06.005 · Cited by 314
Metadata
- Authors
- Urhausen, A., Albers, T., & Kindermann, W.
- Venue
- Heart
- Publisher
- BMJ
- Published
- 2004-04-14
- Volume
- 90
- Issue
- 5
- Pages
- 496-501
- ISSN
- 1355-6037 (ISSN-L)
- 1468-201X
- OpenAlex
- W2163690071
- Cited by
- 275
- References
- 23
- FWCI
- 6.87
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Are the cardiac effects of anabolic steroid abuse in strength athletes reversible? https://app.cochat.ai/papers/10.1136/hrt.2003.015719
- The paper
- Urhausen, A., Albers, T., & Kindermann, W. (2004). Are the cardiac effects of anabolic steroid abuse in strength athletes reversible? Heart. https://doi.org/10.1136/hrt.2003.015719
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.